Néphropathie And NotO. Gribouval

List of bibliographic references

Number of relevant bibliographic references: 8.

Ident.	Authors (with country if any)	Title
001340	Bakhtawar K. Mahmoodi [États-Unis, Pays-Bas] ; Kunihiro Matsushita [États-Unis] ; Mark Woodward [États-Unis, Australie] ; Pester Blankestijn [Pays-Bas] ; Massimo Cirillo [Italie] ; Takayoshi Ohkubo [Japon] ; Peter Rossing [Danemark] ; Mark J. Sarnak [États-Unis] ; Benedicte Stengel [France] ; Kazumasa Yamagishi [Japon] ; Kentaro Yamashita [Japon] ; LUXIA ZHANG [République populaire de Chine] ; Josef Coresh [États-Unis] ; Paul E. De Jong [Pays-Bas] ; Brad C. Astor [États-Unis]	Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis
002467	Liffert Vogt [Pays-Bas, Italie] ; Carlos Chiurchiu [Italie] ; Harbajan Chadha-Boreham [Suisse] ; Parisa Danaietash [Suisse] ; Jasper Dingemanse [Suisse] ; Samy Hadjadj [France] ; Henry Krum [Australie] ; Gerjan Navis [Pays-Bas] ; Eric Neuhart [Suisse] ; Aneliya I. Parvanova [Italie] ; Piero Ruggenenti [Italie] ; Arend Jan Woittiez [Pays-Bas] ; Reuven Zimlichman [Israël] ; Giuseppe Remuzzi [Italie] ; Dick De Zeeuw [Pays-Bas]	Effect of the Urotensin Receptor Antagonist Palosuran in Hypertensive Patients With Type 2 Diabetic Nephropathy
002C50	Josep M. Campistol [Espagne] ; Ioannis N. Boletis [Grèce] ; Jacques Dantai [France] ; Johan W. De Fijter [Pays-Bas] ; Alexandre Hertig [France] ; Hans H. Neumayer [Allemagne] ; Ole Yen [Norvège] ; Julio Pascual [Espagne] ; Erich Pohanka [Autriche] ; Juan C. Ruiz [Espagne] ; Maria P. Scolari [Italie] ; Sergio Stefoni [Italie] ; Daniel Seron [Espagne] ; Vito Sparacino [Italie] ; Wolfgang Arns [Allemagne] ; Jeremy R. Chapman [Australie]	Chronic allograft nephropathy - a clinical syndrome: early detection and the potential role of proliferation signal inhibitors
003989	Isabelle Touitou [France] ; Tamara Sarkisian [Arménie] ; Myrna Medlej-Hashim [Liban] ; Mehmet Tunca [Turquie] ; Avi Livneh [Israël] ; Daniel Cattan [France] ; Fatos Yalcinkaya [Turquie] ; Seza Ozen [Turquie] ; Hassan Majeed [Jordanie] ; Huri Ozdogan [Turquie] ; Daniel Kastner [États-Unis] ; David Booth [Australie] ; Eldad Ben-Chetrit [Israël] ; Denis Pugnere [France] ; Cécile Michelon [France] ; Fabienne Seguret [France] ; Ruth Gershoni-Baruch [Israël]	Country as the primary risk factor for renal amyloidosis in familial mediterranean fever
004C82	Robyn J. Tapp [Australie, France] ; Grad Dip ; Jonathan E. Shaw ; Paul Z. Zimmet ; Beverley Balkau ; Steven J. Chadban ; Andrew M. Tonkin ; Timothy A. Welborn ; Robert C. Atkins	Albuminuria is evident in the early stages of diabetes onset: Results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)
005271	R. G. Langham [Australie] ; D. J. Kelly [Australie] ; A. J. Cox [Australie] ; N. M. Thomson [Australie] ; H. Holthöfer [Finlande] ; P. Zaoui [France] ; N. Pinel [France] ; D. J. Cordonnier [France] ; R. E. Gilbert [Australie]	Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition
005493	J. A. Rossert [France] ; W. M. Mcclellan [États-Unis] ; S. D. Roger [Australie] ; D. L. Verbeelen [Belgique] ; W. H. Hörl [Autriche]	Contribution of anaemia to progression of renal disease: a debate
005B67	F. Bonnet [Australie, France] ; M. E. Cooper [Australie]	Potential influence of lipids in diabetic nephropathy : Insights from experimental data and clinical studies

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024